What federal drug records actually say
TB-500 legal status for patients and pharmacies
The record changed in 2026. A later meeting date passed, but the sources here don't show its result.
What the dated FDA record says about the drug
Chemists first made TB-500 for research, not as an approved medicine. Later, someone asked FDA to let pharmacies mix it. FDA described TB-500 as one copied section from thymosin beta-4. Its place on September 29, 2023 was Category 2 [16]. That group covers drugs with major safety worries. FDA feared that some shot routes could stir the immune system. Important safety facts weren't there either [16]. The record confirms that TB-500 copies part of thymosin beta-4 [16].
The cited record later changed. FDA marked the page current on April 22, 2026. The person who made the request had withdrawn it. TB-500 was no longer in Category 2. FDA hadn't explained what the patient-specific pharmacy rule meant after that [16][17]. TB-500 still lacked drug approval for any use [16]. For you, the dated page leaves the current answer incomplete.
What the past meeting notice cannot tell you
FDA announced a public meeting for July 23–24, 2026. The notice named two chemical forms of TB-500. The group would discuss adding them to an official list. That list covers ingredients pharmacies may sometimes use [18]. BPC-157 appeared on the agenda too, but that doesn't answer the TB-500 question. The TB-500 notice suggested access might change in 2026. It didn't promise a change.
That meeting date has passed. The cited notice is an agenda, not a result [18]. The group only gives advice. FDA makes any final rule [17]. The notice still says "being considered" for July 2026. The TB-500 sources here contain no later decision. This page can't claim that the rule changed in 2026. It also can't claim another result.
What each pharmacy path allows
U.S. law gives pharmacy-mixed drugs two main routes. The first lets a pharmacy prepare medicine for a patient whose name appears on the order. A state-licensed pharmacy or doctor does the work. A valid prescription usually comes first. The other route covers larger batches from registered plants. FDA inspects those plants [17].
The starting powder must qualify too. One route is a written quality standard. Another is use in a drug FDA has approved. A third route is an FDA list that permits the powder [17]. FDA reviews drugs not yet listed. An outside group gives advice during that review. FDA says the TB-500 request was withdrawn. TB-500 also left Category 2, the high-concern group. The page doesn't say if a patient-specific pharmacy may now use it [17]. TB-500 isn't approved or on a final list [16].
What must happen before a pharmacy can mix it
U.S. law starts with one named patient. This is general information, not legal or medical advice. A licensed health worker first examines that person. Next comes a decision: does the mixed drug fit the need? A valid prescription must name the patient [17]. A state-licensed pharmacy may then make one order. A registered plant may make larger batches [17].
A video visit may provide the health check. It doesn't make a barred drug lawful. The prescriber must still have a real care relationship with the patient. A valid prescription is still required [17]. The drug must also fit the rules. FDA still lists safety worries for TB-500. The request was withdrawn, and Category 2 no longer applied. FDA hadn't explained the pharmacy rules after that change [17]. No seller, dose, or shortcut appears here.
What sports drug tests can find in TB-500
Sports rules are separate from pharmacy rules. TB-500 is barred in tested sport. Thymosin beta-4 is barred too. Worldwide sports bans come from the World Anti-Doping Agency. Its rules can apply during and between contests. Chemical tests have found both in horse samples and human samples [4][16]. If you compete under those rules, TB-500 stays barred even if pharmacy rules change.
What FDA has not approved TB-500 to treat
FDA hasn't approved TB-500 to treat any illness [16]. Labs and animal researchers use it. Human studies used full thymosin beta-4, not the small copy [4]. Approval of a finished medicine is one test. Permission to use a starting powder is another. The cited pages show TB-500 passing neither test [16][17].
Why TB-500 rules change by place and use
TB-500 isn't an FDA-approved human drug. Lab suppliers sell it for research. World sports rules bar it in tested events. Australia and New Zealand treat it as a prescription drug [16][4]. Your location and planned use change the legal answer.
FDA put TB-500 in Category 2 in September 2023. That was its high-concern group. The cited page says the request was withdrawn. It also says the drug is no longer in Category 2. The change doesn't say what a patient-specific pharmacy may make [16][17]. This is general information, not legal advice.
What a TB-500 patient and pharmacy would need
FDA records keep the Category 2 listing from September 2023. That was the high-concern group. The records also keep the safety reasons. The cited page says the TB-500 request was withdrawn. It says the drug is no longer in Category 2. FDA hasn't told patient-specific pharmacies what follows [16][17]. In general, mixing needs three things. A licensed health check comes first. One person's prescription and a permitted drug must follow [17]. No pharmacy or seller is named here.
What the older TB-500 record and agenda show
FDA described TB-500 as a copied section from thymosin beta-4. Category 2 became its FDA group on September 29, 2023 [16]. FDA feared that some shot routes could stir the immune system. Important safety information wasn't there either. Category 2 meant FDA could take action when a pharmacy used the drug. The agency wasn't promising to leave the pharmacy alone [17]. A later TB-500 agenda set a discussion for July 23–24, 2026. That date has passed. The cited agenda records a planned meeting, not its result [18].
What the TB-500 sports ban means across borders
Yes, TB-500 is barred in tested sport. Thymosin beta-4 is barred too. World sports rules group them with banned growth and repair drugs. The ban can apply during and between contests. Chemical tests can find both substances [4][16]. FDA pharmacy rules don't change the sports ban. If you compete under a drug code, the ban follows you across borders.